Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to Accelerate Global Growth, Product Commercialization and Innovation
– Genexine to focus on global drug development and commercialization – Near term milestones should drive shareholder value – Renewed effort to expand pipeline with an emphasis on novel, differentiated products SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700) a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the … [Read more…]
